Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio Essence (BIOE) EBIT (2020 - 2025)

Bio Essence has reported EBIT over the past 6 years, most recently at $1.0 million for Q4 2025.

  • Quarterly results put EBIT at $1.0 million for Q4 2025, up 26629.67% from a year ago — trailing twelve months through Dec 2025 was $900011.0 (up 295.89% YoY), and the annual figure for FY2025 was $900011.0, up 295.89%.
  • EBIT for Q4 2025 was $1.0 million at Bio Essence, up from $14253.0 in the prior quarter.
  • Over the last five years, EBIT for BIOE hit a ceiling of $1.0 million in Q4 2025 and a floor of -$261295.0 in Q2 2021.
  • Median EBIT over the past 5 years was -$153861.5 (2022), compared with a mean of -$63684.1.
  • Biggest five-year swings in EBIT: plummeted 524.55% in 2024 and later skyrocketed 26629.67% in 2025.
  • Bio Essence's EBIT stood at -$198769.0 in 2021, then soared by 132.08% to $63759.0 in 2022, then tumbled by 406.59% to -$195476.0 in 2023, then skyrocketed by 101.97% to $3852.0 in 2024, then skyrocketed by 26629.67% to $1.0 million in 2025.
  • The last three reported values for EBIT were $1.0 million (Q4 2025), $14253.0 (Q3 2025), and $61223.0 (Q2 2025) per Business Quant data.